Reduced GPBAR1 expression has been noted in non-alcoholic steatohepatitis models, where GPBAR1 inhibits NLRP3 activation and fosters macrophage M2 polarization to mitigate inflammation [89]. Here, GPBAR1 is linked to metabolic dysfunction-associated steatohepatitis.